
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Medical Journal from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/medical-journal/topic/220/</link>
        <description>Articles tagged with Medical Journal from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Print: Still not dead</title>
          <description>Studies show that printed pieces still hold sway in the industry.</description>
          <link>http://www.mmm-online.com/print-still-not-dead/article/269366/</link>
          <pubDate>Wed, 21 Nov 2012 15:27:57 GMT</pubDate>
          <itunes:summary>Studies show that printed pieces still hold sway in the industry.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>BMJ will require authors to disclose clinical trial data</title>
          <description>Starting next year, the BMJ will not publish academic papers on drugs or devices unless the relevant anonymized patient-level data are made available for third-party study.</description>
          <link>http://www.mmm-online.com/bmj-will-require-authors-to-disclose-clinical-trial-data/article/266263/</link>
          <pubDate>Wed, 31 Oct 2012 18:30:39 GMT</pubDate>
          <itunes:summary>Starting next year, the BMJ will not publish academic papers on drugs or devices unless the relevant anonymized patient-level data are made available for third-party study.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>JAMA taps NEJM&apos;s Easley as publisher</title>
          <description>The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society&apos;s publications, soon to be rolled up into the JAMA brand.</description>
          <link>http://www.mmm-online.com/jama-taps-nejms-easley-as-publisher/article/264293/</link>
          <pubDate>Thu, 18 Oct 2012 19:54:23 GMT</pubDate>
          <itunes:summary>The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society&apos;s publications, soon to be rolled up into the JAMA brand.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Study finds false data top reason for journal retractions</title>
          <description>A study found fraud rampant in retracted journal articles -- and publishers less than transparent about why articles were pulled</description>
          <link>http://www.mmm-online.com/study-finds-false-data-top-reason-for-journal-retractions/article/261892/</link>
          <pubDate>Tue, 02 Oct 2012 17:06:10 GMT</pubDate>
          <itunes:summary>A study found fraud rampant in retracted journal articles -- and publishers less than transparent about why articles were pulled</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Quadrant buys IMNG, becoming biggest medical publisher by ad revenue</title>
          <description>Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.</description>
          <link>http://www.mmm-online.com/quadrant-buys-imng-becoming-biggest-medical-publisher-by-ad-revenue/article/258366/</link>
          <pubDate>Mon, 10 Sep 2012 19:18:42 GMT</pubDate>
          <itunes:summary>Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>New ad model fosters pharma&apos;s leap to digital, publisher finds</title>
          <description>Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.</description>
          <link>http://www.mmm-online.com/new-ad-model-fosters-pharmas-leap-to-digital-publisher-finds/article/252055/</link>
          <pubDate>Thu, 26 Jul 2012 16:38:28 GMT</pubDate>
          <itunes:summary>Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Roundtable outlines path for publisher, pharma credibility</title>
          <description>In an effort to shore up their reputations, pharma and professional publishers have come together to craft an accountability plan.</description>
          <link>http://www.mmm-online.com/roundtable-outlines-path-for-publisher-pharma-credibility/article/242341/</link>
          <pubDate>Wed, 23 May 2012 20:19:00 GMT</pubDate>
          <itunes:summary>In an effort to shore up their reputations, pharma and professional publishers have come together to craft an accountability plan.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>JAMA feature aims to spark debate and hits a nerve</title>
          <description>Journals are a curious media form in that they provide fodder for debate on medical topics, but not a forum in which to hold one. Enter JAMA&apos;s new Viewpoint feature.</description>
          <link>http://www.mmm-online.com/jama-feature-aims-to-spark-debate-and-hits-a-nerve/article/239289/</link>
          <pubDate>Wed, 02 May 2012 15:00:35 GMT</pubDate>
          <itunes:summary>Journals are a curious media form in that they provide fodder for debate on medical topics, but not a forum in which to hold one. Enter JAMA&apos;s new Viewpoint feature.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Harvard urges faculty to ditch journals</title>
          <description>An email from Harvard University&apos;s Faculty Advisory Council over the cost of professional journals has touched off the latest round in the Universities vs Publishers sparring match.</description>
          <link>http://www.mmm-online.com/harvard-urges-faculty-to-ditch-journals/article/238054/</link>
          <pubDate>Tue, 24 Apr 2012 18:35:17 GMT</pubDate>
          <itunes:summary>An email from Harvard University&apos;s Faculty Advisory Council over the cost of professional journals has touched off the latest round in the Universities vs Publishers sparring match.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Journal &quot;pharmascolds&quot; skew policy, says study</title>
          <description>Medical journal coverage of the question of physician-industry relationships is &quot;unbalanced&quot; and may be skewing public policy towards ever-more restrictive safeguards against industry influence.</description>
          <link>http://www.mmm-online.com/journal-pharmascolds-skew-policy-says-study/article/236332/</link>
          <pubDate>Thu, 12 Apr 2012 20:56:25 GMT</pubDate>
          <itunes:summary>Medical journal coverage of the question of physician-industry relationships is &quot;unbalanced&quot; and may be skewing public policy towards ever-more restrictive safeguards against industry influence.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  